C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673)
06/2011
06/28/2011	US7968547 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
06/28/2011	CA2635196C Glucocorticoid receptor modulators
06/23/2011	WO2011018445A3 Process for the preparation of (r)-2-phenyl propionic acid derivatives
06/23/2011	US20110152290 Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals
06/23/2011	US20110152261 Organic compounds
06/23/2011	US20110147720 Novel Quinoxaline Derivatives and Their Use in Organic Light-Emitting Diode Device
06/23/2011	US20110145970 Detection and use of low molecular-weight modulators of the cold-menthol receptor trpm8
06/22/2011	EP2334643A1 Phenethylamide derivatives and their heterocyclic analogues
06/22/2011	EP2334183A1 Sulfonamide derivative metabotropic glutamate r4 ligands
06/22/2011	EP1968951B1 Novel n-(fluoro-pyrazinyl)-phenylsulfonamid.es as moodulators of chemokine receptor ccr4.
06/22/2011	CN102105453A Therapeutic agent for chronic renal failure
06/22/2011	CN102105437A Adamantyl diamide derivatives and uses of same
06/22/2011	CN101648917B Mequindox metabolic product and preparation method and application thereof
06/21/2011	US7964725 Heteroarylbenzamide derivatives for use in the treatment of diabetes
06/21/2011	US7964605 Phenyl piperazine compounds, pharmaceutical composition comprising the same, and use thereof
06/21/2011	US7964601 Agonist or antgonist and binders and inversion of agonist
06/21/2011	US7964600 Indoles, 1H-indazoles, 1,2-benzisoxazoles, and 1,2-benzisothiazoles, and preparation and uses thereof
06/21/2011	US7964399 Nucleotide sequence vector that encodes a truncated Flk-1 protein which inhibits the binding of VEGF; uses for evaluate and screen of cancer drugs; as biodrug for modulating vasculogenesis and angiogenesis, inhibiting the tumor growth
06/21/2011	CA2641379C Heterobicyclic sulfonamide derivatives for the treatment of diabetes
06/21/2011	CA2554437C Amide derivatives, process for preparation thereof and use thereof as insecticide
06/21/2011	CA2359115C Acyl derivatives which treat vla-4 related disorders
06/16/2011	WO2011071136A1 Therapeutic agent for fibromyalgia
06/16/2011	WO2011071095A1 Benzamide compound
06/16/2011	US20110144338 Methods of reducing risk of infection from pathogens
06/16/2011	US20110144336 Method for Preparation of Piperazindione Derivatives
06/16/2011	US20110144120 Phenyl-alkyl piperazines having tnf-modulating activity, preparation method, and therapeutic use thereof
06/16/2011	US20110144107 Compounds and compositions useful for the treatment of malaria
06/16/2011	US20110144060 Substituted pyrazinone melanin concentrating hormone receptor-1 antagonists and methods
06/16/2011	US20110143951 Mass markers and methods
06/16/2011	US20110143939 Quinoxalin-2-one derivatives, compositions which protect useful plants and comprise these derivatives, and processes for their preparation and their use
06/16/2011	US20110142759 Agents and methods for the imaging of myelin basic protein
06/16/2011	US20110140092 Charge transport compositions and electronic devices made with such compositions
06/16/2011	CA2783537A1 Benzamide compound
06/15/2011	EP2333113A1 Dark quenchers for donor-acceptor energy transfer
06/15/2011	EP2332912A1 Heteroarylaminosulfonylphenylderivates for use as sodium or calcium channel blockers in the treatment of pain
06/15/2011	EP2331499A1 Cold menthol receptor antagonists
06/15/2011	EP2185561B1 1,2,3,4-tetrahydropyrrolo(1,2-a)pyrazine-6-carboxamide and 2,3,4,5-tetrahydropyrrolo(1,2-a)-diazepine-7-carboxamide derivatives, preparation and therapeutic use thereof
06/15/2011	CN102099338A Heterocyclic derivatives that are used in the treatment of neurodegenerative diseases
06/14/2011	US7960433 Treatment of chemokine mediated diseases
06/14/2011	US7960391 Heterocyclylethylbenzamide derivatives
06/14/2011	US7960384 Dipeptidyl peptidase inhibitors
06/09/2011	WO2011067306A1 Cyclohexane derivatives as inhibitors of acetyl-coa carboxylase (acc)
06/09/2011	WO2010143168A3 Compounds useful for treating cancer
06/09/2011	US20110136831 N-2-(Hetero)Arylethylcarboxamide Derivative, and Pest-Controlling Agent Comprising the Same
06/09/2011	US20110136828 Substituted n-oxide pyrazine derivatives
06/09/2011	US20110135599 Antiviral compounds
06/09/2011	US20110133173 Charge transport compositions and electronic devices made with such compositions
06/08/2011	EP2328877A2 1,4-benzoxazine compounds and derivatives thereof as therapeutic drugs for the treatment of neurodegenerative conditions
06/08/2011	EP2328413A2 Pesticidal compositions
06/08/2011	CN1890224B 6-substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose)polymerase inhibitors
06/08/2011	CN1816544B Immunosuppressant compounds and compositions
06/08/2011	CN102089291A Cyclopentylacrylic acid amide derivative
06/08/2011	CN102089289A Novel heterocyclyl compounds for treatment of cardiovascular disease
06/07/2011	US7956057 Imidazole compounds
06/07/2011	CA2562130C 2-propene-1-ones as hsp 70 inducers
06/07/2011	CA2386515C Piperazine derivatives
06/03/2011	WO2011065519A1 Substituted oxopiperazine compound
06/02/2011	US20110130404 Quinoxalinedione derivatives
06/01/2011	EP2327701A1 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain
06/01/2011	EP2327699A1 Glucocorticoid receptor agonist comprising novel 1,2,3,4-tetrahydroquinoxaline derivative containing phenyl group having sulfonic acid ester structure introduced therein as substituent
06/01/2011	EP1379510B1 Aryl and heteroaryl urea chk1 inhibitors for use as radiosensitizers and chemosensitizers
06/01/2011	DE102010042867A1 Use of heterocyclic compounds as herbicides and for controlling undesirable plants in culture of useful plants e.g. wheat, barley, rye, oats, millet and rice
06/01/2011	CN102083793A Protease inhibitors
06/01/2011	CN101580494B Method for extracting phenazine from RT base production waste
06/01/2011	CN101070300B Linonene anologs and its preparing method and use
05/2011
05/31/2011	US7951830 Compounds effecting glucokinase
05/31/2011	US7951809 Inhibitors of p38
05/31/2011	US7951806 Plasminogen activator inhibitor-1 inhibitor
05/31/2011	CA2616271C Highly efficient absorbents for acidic gas separation
05/31/2011	CA2501365C Inhibitors of akt activity
05/31/2011	CA2475764C New inhibitors of histone deacetylase
05/26/2011	US20110124867 Process and intermediates for the Synthesis of heterocyclic Substituted Piperazines with CXCR3 Antagonist Activity
05/26/2011	US20110124673 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors
05/26/2011	US20110124653 Aryl-sulphonamidic dimers as metalloproteases inhibitors
05/26/2011	US20110124651 Fluorine-containing organosulfur compound and pesticidal composition thereof
05/26/2011	US20110124598 Chemical compounds
05/25/2011	EP2325170A1 Substituted quinolinones having herbicidal action
05/25/2011	EP2325169A2 Lisofylline analogues and their pharmeacuetical uses
05/25/2011	CN1926094B Amide derivatives, process for production of the same, and method for application thereof as insecticide
05/25/2011	CN102076669A Substituted n-oxide pyrazine derivatives
05/25/2011	CN102076662A Alpha-mercapto-amides
05/25/2011	CN102070540A 1-oxygen-2-(1-ethoxy)-3-methyl-quinoxaline, and preparation method and application thereof
05/25/2011	CN102070539A 1-oxo-2-methyl-3-(1-ethoxyl)-quinoxaline and preparation method and application thereof
05/24/2011	US7947834 Substituted quinoxalines, their preparation and their therapeutical use as 11βHSD1 modulators
05/24/2011	US7947833 Preparation of quinoxaline compounds
05/24/2011	US7947718 Isoxazole compounds as histamine H3 modulators
05/24/2011	US7947711 Bicyclic-substituted amines as histamine-3 receptor ligands
05/24/2011	US7947685 Pyrazine-2-carboxyamide derivatives
05/24/2011	US7947684 anticoagulants; immunomoderators; antiinflammatory agents
05/24/2011	US7947513 Sets and compositions pertaining to analyte determination
05/24/2011	CA2499690C Diaryl ethers as opioid receptor antagonist
05/24/2011	CA2464807C Phenyl-propargylether derivatives
05/24/2011	CA2303428C .alpha.-ketoamide multicatalytic protease inhibitors
05/19/2011	WO2011059042A1 Aromatic ring compound
05/19/2011	WO2011005731A3 Process for making cgrp receptor antagonist
05/19/2011	WO2010149598A3 Heterocyclic antiviral compound
05/19/2011	US20110118464 Halogenated xanthine derivatives and precursors thereof for anti-cancer and anti-metastasis activity and preparing method thereof
05/19/2011	US20110118270 Heterocyclic derivatives that are used in the treatment of neurodegenerative diseases
05/19/2011	US20110118254 Therapeutic agent for inflammatory bowel disease
05/19/2011	US20110118244 Factor xa inhibitors

1 ... 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 ... 187